123 related articles for article (PubMed ID: 2970273)
1. Effect of stilboestrol and testosterone on the incorporation of 75selenomethionine by prostatic carcinoma cells.
Ferro MA; Heinemann D; Smith PJ; Symes MO
Br J Urol; 1988 Aug; 62(2):166-72. PubMed ID: 2970273
[TBL] [Abstract][Full Text] [Related]
2. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
3. The tumor-inhibiting effect of diethylstilbestrol and its diphosphate on the Nb-H and Nb-R prostatic carcinomas of the rat.
Schneider MR; Humm A; Graf AH
J Cancer Res Clin Oncol; 1990; 116(2):159-67. PubMed ID: 2324159
[TBL] [Abstract][Full Text] [Related]
4. The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
Goldenberg SL; Bruchovsky N; Rennie PS; Coppin CM
J Urol; 1988 Dec; 140(6):1460-5. PubMed ID: 2973529
[TBL] [Abstract][Full Text] [Related]
5. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
Robinson MR
Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
[No Abstract] [Full Text] [Related]
6. Effects of steroid hormones and antihormones in cultured cells.
Jung-Testas I; Baulieu EE
Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
[TBL] [Abstract][Full Text] [Related]
7. Effect of diethylstilbestrol diphosphate on activity of 5 alpha-reductase in human prostate.
Usui T; Ishibe T; Nakamura K; Mizutani M; Yasukawa A
Arch Androl; 1987; 19(3):229-35. PubMed ID: 2461177
[TBL] [Abstract][Full Text] [Related]
8. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
Robinson MR
Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402
[No Abstract] [Full Text] [Related]
9. Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells.
Schulz P; Bauer HW; Brade WP; Keller A; Fittler F
Cancer Res; 1988 May; 48(10):2867-70. PubMed ID: 2834049
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of testosterone on gap junctional intercellular communication of human transitional cell carcinoma cell lines.
Kihara K; Fukui I; Higashi Y; Oshima H
Cancer Res; 1990 May; 50(9):2848-52. PubMed ID: 2139361
[TBL] [Abstract][Full Text] [Related]
11. Testosterone-induced responsiveness to androgen in Shionogi mouse carcinoma cells.
Jung-Testas I; Baulieu EE
Exp Cell Res; 1987 May; 170(1):250-8. PubMed ID: 2952518
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the regulation of prostatic oxytocin by gonadal steroids in the rat.
Jenkin L; Nicholson HD
J Androl; 1999; 20(1):80-7. PubMed ID: 10100477
[TBL] [Abstract][Full Text] [Related]
13. The changes in the binding capacity of testosterone-oestradiol binding globulin (TeBG) following castration and DES-D administration in patients with prostatic carcinoma.
Usui T; Sagami K; Kitano T; Nihira H; Miyachi Y
Urol Res; 1982; 10(3):119-22. PubMed ID: 6890254
[TBL] [Abstract][Full Text] [Related]
14. Testosterone-induced DNA synthesis in cultured rat ventral prostate. I. Effects of cyproterone acetate.
Buchanan LJ; Riches AC
J Anat; 1986 Oct; 148():159-67. PubMed ID: 2961721
[TBL] [Abstract][Full Text] [Related]
15. Effects of androgen and antiandrogen on growth, morphology and synthesis of specific proteins in mouse mammary carcinoma cells.
Jung-Testas I; Gasc JM; Baulieu EE
J Steroid Biochem; 1988; 30(1-6):353-8. PubMed ID: 2968485
[TBL] [Abstract][Full Text] [Related]
16. STILBOESTROL DIPHOSPHATE (HONVAN) IN THE TREATMENT OF ACUTE URINARY RETENTION DUE TO PROSTATIC CARCINOMA.
PARTON I
Br J Urol; 1965 Jun; 37():314-6. PubMed ID: 14314433
[No Abstract] [Full Text] [Related]
17. Radioimmunoassay of diethylstilbestrol in plasma of patients with prostatic carcinoma.
Usui T; Nakamura K; Osumi T; Ishibe T; Kitano T; Kambegawa A; Miyachi Y
Arch Androl; 1984; 12(2-3):243-9. PubMed ID: 6508431
[TBL] [Abstract][Full Text] [Related]
18. Role of the mitochondrial bc1-complex in the cytotoxic action of diethylstilbestrol-diphosphate toward prostatic carcinoma cells.
Schulz P; Link TA; Chaudhuri L; Fittler F
Cancer Res; 1990 Aug; 50(16):5008-12. PubMed ID: 2165852
[TBL] [Abstract][Full Text] [Related]
19. Re: The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
Varenhorst E; Wallentin L
J Urol; 1989 Nov; 142(5):1335-6. PubMed ID: 2530361
[No Abstract] [Full Text] [Related]
20. Testosterone action in the rat ventral prostate. The effects of diethylstilboestrol and cyproterone acetate on the metabolism of ( 3 H)testosterone and the retention of labelled metabolites by rat ventral prostate in vivo and in vitro.
Belham JE; Neal GE
Biochem J; 1971 Nov; 125(1):81-91. PubMed ID: 5158924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
